Profiel
Mr. Edwin Elmhirst is a Data Journalist at Evaluate Ltd.
He is responsible for a variety of behind-the-scenes functions that go into the day-to-day running of Evaluate Vantage, including data handling and analysis.
He also has prior freelance experience in editing scientific publications.
He has under- and postgraduate degrees in biomedical science.
Actieve functies van Edwin Elmhirst
| Bedrijven | Functie | Begin |
|---|---|---|
Evaluate Ltd.
 Evaluate Ltd. Investment ManagersFinance Part of Citeline, Inc., Evaluate Ltd. is a British company that provides trusted commercial intelligence and predictive analytics for the pharmaceutical industry and their advisors. The company is based in London, UK. Evaluate offers unique and dynamic insights into pharma asset risk and commercial potential alongside a comprehensive view of the pharmaceutical market landscape through their Evaluate Omnium and Evaluate Pharma platforms. The company's award-winning editorial team, Evaluate Vantage, provides thought-provoking news and insights into current and future industry developments. Evaluate has been a partner to industry-leading organizations for over 20 years. The company was founded in 1996. Deborah Karen Kobewka has been the CEO of the company since 2019. Evaluate was acquired by Managed Markets Insight & Technology LLC, part of Citeline, Inc. from November 01, 2022 on August 20, 2021. | Corporate Officer/Principal | 01-03-2015 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Evaluate Ltd.
Evaluate Ltd. Investment ManagersFinance Part of Citeline, Inc., Evaluate Ltd. is a British company that provides trusted commercial intelligence and predictive analytics for the pharmaceutical industry and their advisors. The company is based in London, UK. Evaluate offers unique and dynamic insights into pharma asset risk and commercial potential alongside a comprehensive view of the pharmaceutical market landscape through their Evaluate Omnium and Evaluate Pharma platforms. The company's award-winning editorial team, Evaluate Vantage, provides thought-provoking news and insights into current and future industry developments. Evaluate has been a partner to industry-leading organizations for over 20 years. The company was founded in 1996. Deborah Karen Kobewka has been the CEO of the company since 2019. Evaluate was acquired by Managed Markets Insight & Technology LLC, part of Citeline, Inc. from November 01, 2022 on August 20, 2021. | Finance |
